Hims & Hers Health (HIMS) News Today $57.77 -0.05 (-0.09%) Closing price 09/22/2025 03:58 PM EasternExtended Trading$57.72 -0.05 (-0.08%) As of 09/22/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period 3 Big Short Interest Names With Bullish Setups (HIMS)HIMS, DLO, and TEM combine high short interest with bullish chart setups, creating strong breakout potential as market momentum stays hot.September 22 at 12:04 PM | marketbeat.comHims & Hers Stock Pushes to Highs on Healthcare Rate Cut FrenzyHims & Hers Health posted 73% revenue growth and 31% more subscribers in Q2. With analyst targets hitting $68, is now the time to buy HIMS?September 21 at 10:08 AM | marketbeat.comHims & Hers Health, Inc. $HIMS Shares Sold by Abacus FCF Advisors LLCSeptember 21 at 5:37 AM | marketbeat.comTTP Investments Inc. Takes $249,000 Position in Hims & Hers Health, Inc. $HIMSSeptember 21 at 5:34 AM | marketbeat.comInsider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 2,637 Shares of StockSeptember 20 at 6:10 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Insider Sells $424,705.00 in StockSeptember 20 at 5:47 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Insider Patrick Harrison Carroll Sells 10,021 SharesSeptember 20 at 5:46 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Insider Sells $694,324.50 in StockSeptember 20 at 5:46 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) CEO Sells $3,292,612.70 in StockSeptember 20 at 5:46 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Insider Soleil Boughton Sells 2,637 SharesSeptember 20 at 9:21 AM | insidertrades.comAnalysts Set Hims & Hers Health, Inc. (NYSE:HIMS) PT at $38.92September 20 at 2:25 AM | americanbankingnews.comModerately bullish activity in Hims and Hers Health with shares up 2.79%September 19, 2025 | msn.comHims & Hers Health (NYSE:HIMS) Shares Up 9.3% - Time to Buy?September 19, 2025 | marketbeat.comBerger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary DutiesSeptember 19, 2025 | prnewswire.comOscar Health Set For HIMS-Style Moonshot? Shorts Could Burn As ACA Buzz BuildsSeptember 19, 2025 | benzinga.comHims & Hers Health, Inc. $HIMS Shares Sold by Voya Investment Management LLCSeptember 19, 2025 | marketbeat.comInsider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 4,150 Shares of StockSeptember 18, 2025 | marketbeat.comHims & Hers Health (NYSE:HIMS) CEO Andrew Dudum Sells 128,127 SharesSeptember 18, 2025 | marketbeat.comHims & Hers Health (NYSE:HIMS) CFO Oluyemi Okupe Sells 145,000 SharesSeptember 18, 2025 | marketbeat.comHims & Hers Health: Bumpy Ride Will EndSeptember 18, 2025 | seekingalpha.comHims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFsSeptember 18, 2025 | benzinga.comInsider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 4,150 Shares of StockSeptember 18, 2025 | insidertrades.comHims & Hers Is An Interesting Story, But Not The One I Signed Up For - DowngradeSeptember 18, 2025 | seekingalpha.comU.S. FDA sends drug advertising warning letters to Lilly, Novo, HimsSeptember 18, 2025 | msn.comLake Hills Wealth Management LLC Makes New Investment in Hims & Hers Health, Inc. $HIMSSeptember 18, 2025 | marketbeat.comShould Investors Rethink Hims & Hers After FDA Flags Super Bowl Ad and Shares Double in 2025?September 18, 2025 | finance.yahoo.comRep. Lisa C. McClain Buys Hims & Hers Health, Inc. (NYSE:HIMS) StockSeptember 17, 2025 | marketbeat.comHims & Hers Health's Options Frenzy: What You Need to KnowSeptember 17, 2025 | benzinga.comHims & Hers Health (NYSE:HIMS) Stock Price Down 8.4% - What's Next?September 17, 2025 | marketbeat.comHims & Hers Health, Inc. $HIMS Stock Position Raised by Fiduciary Alliance LLCSeptember 17, 2025 | marketbeat.comRange Financial Group LLC Invests $996,000 in Hims & Hers Health, Inc. $HIMSSeptember 17, 2025 | marketbeat.comStrs Ohio Buys New Shares in Hims & Hers Health, Inc. $HIMSSeptember 17, 2025 | marketbeat.comBelpointe Asset Management LLC Has $225,000 Position in Hims & Hers Health, Inc. $HIMSSeptember 17, 2025 | marketbeat.comHims & Hers falls 8% as FDA issues warning letter over compounded weight loss drugSeptember 17, 2025 | msn.comHims & Hers Health (HIMS) Stock Trades Down, Here Is WhySeptember 17, 2025 | msn.comFDA takes aim at Hims & Hers, weight loss drugs in new advertising blitzSeptember 17, 2025 | msn.comHims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Reduce" from AnalystsSeptember 17, 2025 | marketbeat.comTrump Drug Ad Crackdown: FDA Warns Novo Nordisk, Eli Lilly, HimsSeptember 16, 2025 | forbes.comFDA Warns Hims Over Ads About Compounded Weight-Loss DrugsSeptember 16, 2025 | forbes.comUS FDA warns Hims & Hers over misleading claims on diabetes, weight-loss drugsSeptember 16, 2025 | reuters.comHuge News for Hims & Hers StockSeptember 16, 2025 | fool.comHims & Hers Is in the FDA’s Crosshairs. It’s a Risk to the Stock.September 16, 2025 | msn.comBerger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary DutiesSeptember 15, 2025 | prnewswire.comHims & Hers shares drop after FDA chief flags ad violationsSeptember 15, 2025 | za.investing.com7,534 Shares in Hims & Hers Health, Inc. $HIMS Bought by City Center Advisors LLCSeptember 15, 2025 | marketbeat.comIntech Investment Management LLC Boosts Stake in Hims & Hers Health, Inc. $HIMSSeptember 15, 2025 | marketbeat.comCanaccord Genuity Group Reaffirms "Buy" Rating for Hims & Hers Health (NYSE:HIMS)September 15, 2025 | americanbankingnews.comHims & Hers Health's (HIMS) "Buy" Rating Reiterated at Canaccord Genuity GroupSeptember 14, 2025 | marketbeat.comTime to Bet on Hims & Hers Health (HIMS)? Analysts Point to Several Growth CatalystsSeptember 14, 2025 | msn.comArete Wealth Advisors LLC Purchases Shares of 10,185 Hims & Hers Health, Inc. $HIMSSeptember 14, 2025 | marketbeat.com Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos HIMS Media Mentions By Week HIMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.360.73▲Average Medical News Sentiment HIMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼5136▲HIMS Articles Average Week Get the Latest News and Ratings for HIMS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Hims & Hers Health and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NTRA News Today FMS News Today GH News Today RDNT News Today BTSG News Today SHC News Today OPCH News Today WGS News Today SGRY News Today CON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
